TREATMENT WITH INFLIXIMAB IN PATIENT WITH EARLY POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS
Abstract
Key words: children, early juvenile rheumatoid arthritis, treatment, infliximab.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(5):127-132)
About the Authors
T.V. SleptsovaRussian Federation
E.I. Alexeeva
Russian Federation
S.I. Valieva
Russian Federation
T.M. Bzarova
Russian Federation
A.O. Lisitsin
Russian Federation
K.B. Isaeva
Russian Federation
R.V. Denisova
Russian Federation
References
1. Bradley J.R. TNF–mediated inflammatory disease. J. Pathol. 2008; 214: 149–160.
2. Ackermann C., Kavanaugh A. Tumor necrosis factor as a therapeutic target of rheumatologic disease. Expert Opin. Ther. Targets. 2007; 11: 1369–1384.
3. Smolen J.S., Han C., van der Heijde D.M. et al. Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade. Ann. Rheum. Dis. 2009; 68(6): 823–827.
4. Takeuchi T., Yamanaka H., Inoue E. et al. Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM–2J). Mod. Rheumatol. 2008; 18 (5): 447–454.
5. Pavelka K., Gatterová J., Tegzová D. et al. Radiographic progression of rheumatoid arthritis in patients from the Czech National Registry receiving infliximab treatment. Clin. Exp. Rheumatol. 2007; 25(4): 540–555.
6. Corona F., Scarazatti M., Dell’erra L., Beltramelli M., Carnelli V., Bardare M. Active refractory juvenile idiopathic arthritis: treatment with infliximab. Efficacy and safety. Ital. J. Pediatr. 2004; 30: 165–168.
7. Masatlioglu S., Gogus F., Cevirgen D., et al. Infliximab in the treatment of refractory juvenile idiopathic arthritis. Arthritis Rheum. 2002; 46: 481.
8. Алексеева А.М. Эффективность и безопасность блокатора ФНО – инфликсимаба у больных ювенильным ревматоидным артритом. Автореферат дис. …канд. мед. наук. М. 2008. 24 с.
9. Алексеева Е.И., Бзарова Т.М., Валиева С.И. и др. Эффективность лечения инфликсимабом суставных вариантов ювенильного ревматоидного артрита. XIII Российский национальный конгресс «Человек и лекарство». Тезисы докладов. М. 2006. С. 351–352.
10. Chaturvedi V.P. Pilot study of chimeric monoclonal anti-tumor necrosis factor alpha anti-body (infliximab) with methotrexate in polyarticular juvenile idiopathic arthritis [abstract]. American College of Rheumatology 66th Annual Scientific Meeting. October 24–25, 2002. New Orleans. LA. Abstract LB12.
11. Lovell D.J., Ruperto N., Cuttica R. et al. Randomized trial of infliximab plus methotrexate for the treatment of polyarticular juvenile rheumatoid arthritis [poster]. American College of Rheumatology 68th Annual Scientific Meeting, October 16–21, 2004. San Antonio. TX. Poster 523.
12. Mangge H., Heinzl B., Grubbauer H-M. et al. Therapeutic experience with infliximab in a patient with polyarticular juvenile idiopathic arthritis and uveitis. Rheumatol. Int. 2003; 23: 258–261.
13. Allaart C.F., Breedveld F.C., Dijkmans BA. et al. Treatment of recent onset rheumatoid arthritis: lessons from the BeSt study. J. Rheumatol. Suppl. 2007; 80(10): 25–33.
14. Van der Kooij S.M., le Cessie S., Goekoop–Ruiterman Y.P. et.al. Clinical and radiological efficacy of initial delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis. Ann. Rheum. Dis. 2009; 68 (7): 1153–1158.
15. Durez P., Malghem J., Nzeusseu Toukap A. et al. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab and methotrexate in combination with intravenous pulse methylprednisolone. Arthritis Rheum. 2007; 56(12): 3919–3927.
16. Quinn M.A., Conaghan P.G., O’Connor P.J. et al. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve month randomized, double blind, placebo controlled trial. Arthritis Rheum. 2005; 52(1): 27–35.
17. Takeuchi T. Clinical and radiological efficacy of initial VS delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis. Nippon Rinsho. 2009; 67(5): 33–36.
18. Takeuchi T. Indications for and use of biologics in early rheumatoid arthritis based on the evidence. Nippon Rinsho. 2009; 67 (5): 1043–1049.
Review
For citations:
Sleptsova T., Alexeeva E., Valieva S., Bzarova T., Lisitsin A., Isaeva K., Denisova R. TREATMENT WITH INFLIXIMAB IN PATIENT WITH EARLY POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS. Current Pediatrics. 2010;9(5):127-132.
Email this article 
